FDA Awards Westat Contracts to Test Labeling and Messaging to Consumers
Retrieved on:
Tuesday, December 13, 2022
Pediatrics, China Health and Nutrition Survey, Food, Transport, Doctor of Philosophy, Food safety, Research, Focus, Data collection, Knowledge, WIC, FDA, Food and Drug Administration Amendments Act of 2007, Literacy, Policy, Government, CBD, Multimedia, Public health, Diet, Safety, Education, Salmon, SNAP, Health, Medical device, Risk management, Dietary supplement, Westat
ROCKVILLE, Md., Dec. 13, 2022 /PRNewswire/ -- The Food and Drug Administration (FDA) has awarded Westat over a dozen tasks in 2022, including literature reviews, focus groups, cognitive interviews, pretesting, and experimental studies. This work is aimed at providing insight on consumer and health care professionals' perceptions of, motivations toward, and attitudes about products under FDA's oversight, and will help FDA move forward with more accurate and informative messaging.
Key Points:
- FDA has selected Westat to test messaging on consumers' perceptions, motivations, and attitudes with a wide range of food and prescription products and medical devices.
- The data will help FDA more clearly communicate to diverse audiences about the safety and use of the consumer goods it regulates.
- These research tasks call on Westat to provide accurate, timely, and insightful data to inform FDA policy.
- There's a lot at stakeconsumer education and safety relies on consumer understanding of sometimes complicated labeling and messaging around products and devices.